{"id":56019,"date":"2023-04-19T21:06:27","date_gmt":"2023-04-19T19:06:27","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/mideo-founder-and-ceo-ferdinando-mirarchi-do-and-professor-thaddeus-pope-phd-to-be-published-in-the-journal-of-patient-safety\/"},"modified":"2023-04-19T21:06:27","modified_gmt":"2023-04-19T19:06:27","slug":"mideo-founder-and-ceo-ferdinando-mirarchi-do-and-professor-thaddeus-pope-phd-to-be-published-in-the-journal-of-patient-safety","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/mideo-founder-and-ceo-ferdinando-mirarchi-do-and-professor-thaddeus-pope-phd-to-be-published-in-the-journal-of-patient-safety\/","title":{"rendered":"MIDEO Founder and CEO, Ferdinando Mirarchi, DO, and Professor Thaddeus Pope, PhD, to be Published in The Journal of Patient Safety"},"content":{"rendered":"
\n

ERIE, Pa.–(BUSINESS WIRE)–Founder and CEO of M<\/b>y I<\/b>nformed D<\/b>ecision on VidEO<\/b> (MIDEO) technology and MIDEO Health, Ferdinando Mirarchi, DO, and leading law ethicist on end-of-life issues, Professor Thaddeus Pope, PhD, were invited by the Journal of Patient Safety<\/i>, a globally renowned and respected publication, to contribute their expert opinions and solution suggestions regarding patient safety concerns surrounding advance directives (ADs) and portable orders for life-sustaining treatment (POLST). The co-authors have received approval for their article titled, “Widespread Misinterpretation of Advance Directives and POLSTs Threatens Patient Safety and Causes Undertreatment and Overtreatment,” and are set to see their work published both online and in a future journal volume<\/a>.<\/p>\n

<\/a><\/p>\n

\nPertinent to the MIDEO mission of improving patient safety, the article discusses the frequent, recurring discordant medical care and misinterpretation of advance directives (ADs) and portable orders for life-sustaining treatment (POLST). It proceeds to highlight how video can be used as a beneficial tool to accompany written advance directives or POLST orders to improve patient safety. MIDEO Health\u2019s approach of creating a prescription for advance care planning then crafting a video based on that prescription is a real-time example of how the solutions suggested in the article can be deployed immediately. Patients can safely and quickly provide clear direction to medical teams who, in turn, can be confident they are acting in accordance with the patient\u2019s wishes.<\/p>\n

\nDr. Mirarchi and Professor Pope\u2019s dedication to improving advance directive initiatives and educating others on the topic is apparent in this soon-to-be published article.<\/p>\n

\n\u201cProfessor Pope and I are advocates for the safe utilization of advance directives and POLSTs,\u201d said Dr. Mirarchi. \u201cThe resources for improving patient safety are within reach. Therefore, patients and their families deserve the ability to lean on these resources to ensure they are safely cared for at all times. MIDEO is exactly the resource that anyone can lean on, and it is an exciting time at MIDEO Health to know that the TRIAD Research and SMU Law Review on video advance directives are now acting as catalyst to promote change.\u201d<\/p>\n

\nTo review the article in the Journal of Patient Safety<\/i> visit https:\/\/journals.lww.com\/journalpatientsafety\/<\/a>. To learn more about MIDEO Health visit https:\/\/mideohealth.com\/<\/a><\/p>\n

\nAbout MIDEO<\/b><\/p>\n

\nPioneering the future of advance directives, M<\/b>y I<\/b>nformed D<\/b>ecision on VidEO<\/b> (MIDEO) Health provides life-saving technology that combines a standard written advance directive or portable order for life-sustaining treatment (POLST) with video for an easily accessible and informative solution to ensure a patient\u2019s wishes for their care are clearly communicated during any health emergency. Founded by emergency physician Ferdinando Mirarchi, DO, MIDEO is utilized by patients in 43 states and five countries as an effective and safe way to ensure their expectations for care are clearly stated and readily available for access by their treating clinical team. Visit mideohealth.com<\/a> for more.<\/p>\n

Contacts<\/b> <\/p>\n

\nMarty Richmond
\n
richmondm@usacs.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

ERIE, Pa.–(BUSINESS WIRE)–Founder and CEO of My Informed Decision on VidEO (MIDEO) technology and MIDEO Health, Ferdinando Mirarchi, DO, and leading law ethicist on end-of-life issues, Professor Thaddeus Pope, PhD, were invited by the Journal of Patient Safety, a globally renowned and respected publication, to contribute their expert opinions and solution suggestions regarding patient safety … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-56019","6":"format-standard","7":"category-industry"},"yoast_head":"\nMIDEO Founder and CEO, Ferdinando Mirarchi, DO, and Professor Thaddeus Pope, PhD, to be Published in The Journal of Patient Safety - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/mideo-founder-and-ceo-ferdinando-mirarchi-do-and-professor-thaddeus-pope-phd-to-be-published-in-the-journal-of-patient-safety\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MIDEO Founder and CEO, Ferdinando Mirarchi, DO, and Professor Thaddeus Pope, PhD, to be Published in The Journal of Patient Safety - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"ERIE, Pa.–(BUSINESS WIRE)–Founder and CEO of My Informed Decision on VidEO (MIDEO) technology and MIDEO Health, Ferdinando Mirarchi, DO, and leading law ethicist on end-of-life issues, Professor Thaddeus Pope, PhD, were invited by the Journal of Patient Safety, a globally renowned and respected publication, to contribute their expert opinions and solution suggestions regarding patient safety ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/mideo-founder-and-ceo-ferdinando-mirarchi-do-and-professor-thaddeus-pope-phd-to-be-published-in-the-journal-of-patient-safety\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-19T19:06:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230419005906\/en\/1768719\/21\/Mideo_logo-1C.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mideo-founder-and-ceo-ferdinando-mirarchi-do-and-professor-thaddeus-pope-phd-to-be-published-in-the-journal-of-patient-safety\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mideo-founder-and-ceo-ferdinando-mirarchi-do-and-professor-thaddeus-pope-phd-to-be-published-in-the-journal-of-patient-safety\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"MIDEO Founder and CEO, Ferdinando Mirarchi, DO, and Professor Thaddeus Pope, PhD, to be Published in The Journal of Patient Safety\",\"datePublished\":\"2023-04-19T19:06:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mideo-founder-and-ceo-ferdinando-mirarchi-do-and-professor-thaddeus-pope-phd-to-be-published-in-the-journal-of-patient-safety\\\/\"},\"wordCount\":502,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mideo-founder-and-ceo-ferdinando-mirarchi-do-and-professor-thaddeus-pope-phd-to-be-published-in-the-journal-of-patient-safety\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230419005906\\\/en\\\/1768719\\\/21\\\/Mideo_logo-1C.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mideo-founder-and-ceo-ferdinando-mirarchi-do-and-professor-thaddeus-pope-phd-to-be-published-in-the-journal-of-patient-safety\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mideo-founder-and-ceo-ferdinando-mirarchi-do-and-professor-thaddeus-pope-phd-to-be-published-in-the-journal-of-patient-safety\\\/\",\"name\":\"MIDEO Founder and CEO, Ferdinando Mirarchi, DO, and Professor Thaddeus Pope, PhD, to be Published in The Journal of Patient Safety - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mideo-founder-and-ceo-ferdinando-mirarchi-do-and-professor-thaddeus-pope-phd-to-be-published-in-the-journal-of-patient-safety\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mideo-founder-and-ceo-ferdinando-mirarchi-do-and-professor-thaddeus-pope-phd-to-be-published-in-the-journal-of-patient-safety\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230419005906\\\/en\\\/1768719\\\/21\\\/Mideo_logo-1C.jpg\",\"datePublished\":\"2023-04-19T19:06:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mideo-founder-and-ceo-ferdinando-mirarchi-do-and-professor-thaddeus-pope-phd-to-be-published-in-the-journal-of-patient-safety\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mideo-founder-and-ceo-ferdinando-mirarchi-do-and-professor-thaddeus-pope-phd-to-be-published-in-the-journal-of-patient-safety\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mideo-founder-and-ceo-ferdinando-mirarchi-do-and-professor-thaddeus-pope-phd-to-be-published-in-the-journal-of-patient-safety\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230419005906\\\/en\\\/1768719\\\/21\\\/Mideo_logo-1C.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230419005906\\\/en\\\/1768719\\\/21\\\/Mideo_logo-1C.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mideo-founder-and-ceo-ferdinando-mirarchi-do-and-professor-thaddeus-pope-phd-to-be-published-in-the-journal-of-patient-safety\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MIDEO Founder and CEO, Ferdinando Mirarchi, DO, and Professor Thaddeus Pope, PhD, to be Published in The Journal of Patient Safety\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MIDEO Founder and CEO, Ferdinando Mirarchi, DO, and Professor Thaddeus Pope, PhD, to be Published in The Journal of Patient Safety - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/mideo-founder-and-ceo-ferdinando-mirarchi-do-and-professor-thaddeus-pope-phd-to-be-published-in-the-journal-of-patient-safety\/","og_locale":"en_US","og_type":"article","og_title":"MIDEO Founder and CEO, Ferdinando Mirarchi, DO, and Professor Thaddeus Pope, PhD, to be Published in The Journal of Patient Safety - Pharma Trend","og_description":"ERIE, Pa.–(BUSINESS WIRE)–Founder and CEO of My Informed Decision on VidEO (MIDEO) technology and MIDEO Health, Ferdinando Mirarchi, DO, and leading law ethicist on end-of-life issues, Professor Thaddeus Pope, PhD, were invited by the Journal of Patient Safety, a globally renowned and respected publication, to contribute their expert opinions and solution suggestions regarding patient safety ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/mideo-founder-and-ceo-ferdinando-mirarchi-do-and-professor-thaddeus-pope-phd-to-be-published-in-the-journal-of-patient-safety\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-19T19:06:27+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230419005906\/en\/1768719\/21\/Mideo_logo-1C.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/mideo-founder-and-ceo-ferdinando-mirarchi-do-and-professor-thaddeus-pope-phd-to-be-published-in-the-journal-of-patient-safety\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/mideo-founder-and-ceo-ferdinando-mirarchi-do-and-professor-thaddeus-pope-phd-to-be-published-in-the-journal-of-patient-safety\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"MIDEO Founder and CEO, Ferdinando Mirarchi, DO, and Professor Thaddeus Pope, PhD, to be Published in The Journal of Patient Safety","datePublished":"2023-04-19T19:06:27+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/mideo-founder-and-ceo-ferdinando-mirarchi-do-and-professor-thaddeus-pope-phd-to-be-published-in-the-journal-of-patient-safety\/"},"wordCount":502,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/mideo-founder-and-ceo-ferdinando-mirarchi-do-and-professor-thaddeus-pope-phd-to-be-published-in-the-journal-of-patient-safety\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230419005906\/en\/1768719\/21\/Mideo_logo-1C.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/mideo-founder-and-ceo-ferdinando-mirarchi-do-and-professor-thaddeus-pope-phd-to-be-published-in-the-journal-of-patient-safety\/","url":"https:\/\/pharma-trend.com\/en\/mideo-founder-and-ceo-ferdinando-mirarchi-do-and-professor-thaddeus-pope-phd-to-be-published-in-the-journal-of-patient-safety\/","name":"MIDEO Founder and CEO, Ferdinando Mirarchi, DO, and Professor Thaddeus Pope, PhD, to be Published in The Journal of Patient Safety - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/mideo-founder-and-ceo-ferdinando-mirarchi-do-and-professor-thaddeus-pope-phd-to-be-published-in-the-journal-of-patient-safety\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/mideo-founder-and-ceo-ferdinando-mirarchi-do-and-professor-thaddeus-pope-phd-to-be-published-in-the-journal-of-patient-safety\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230419005906\/en\/1768719\/21\/Mideo_logo-1C.jpg","datePublished":"2023-04-19T19:06:27+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/mideo-founder-and-ceo-ferdinando-mirarchi-do-and-professor-thaddeus-pope-phd-to-be-published-in-the-journal-of-patient-safety\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/mideo-founder-and-ceo-ferdinando-mirarchi-do-and-professor-thaddeus-pope-phd-to-be-published-in-the-journal-of-patient-safety\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/mideo-founder-and-ceo-ferdinando-mirarchi-do-and-professor-thaddeus-pope-phd-to-be-published-in-the-journal-of-patient-safety\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230419005906\/en\/1768719\/21\/Mideo_logo-1C.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230419005906\/en\/1768719\/21\/Mideo_logo-1C.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/mideo-founder-and-ceo-ferdinando-mirarchi-do-and-professor-thaddeus-pope-phd-to-be-published-in-the-journal-of-patient-safety\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"MIDEO Founder and CEO, Ferdinando Mirarchi, DO, and Professor Thaddeus Pope, PhD, to be Published in The Journal of Patient Safety"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56019","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=56019"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56019\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=56019"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=56019"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=56019"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}